Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Interactive Brokers Group Inc. Class A Common Stock (IBKR) Price & Performance

Halozyme Therapeutics Inc. Common StockTrade
Interactive Brokers Group Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Halozyme Therapeutics Inc. Common Stock vs Interactive Brokers Group Inc. Class A Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Interactive Brokers Group Inc. Class A Common Stock trades at $87.87 (market cap $39.18B). The key difference: Interactive Brokers Group Inc. Class A Common Stock is far larger — about 3.1× Halozyme Therapeutics Inc. Common Stock's market cap, and Interactive Brokers Group Inc. Class A Common Stock pays a 0.4% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Interactive Brokers Group Inc. Class A Common Stock for 1 Days on average.

HALOIBKR
Market Cap
$12.58B$39.18B
Volume
2,179,2782,996,599
Sector
HealthFinancials
52-Week High
$115.22$98.19
52-Week Low
$61.63$61.05
Typical Hold Time
1 Days1 Days
Enterprise Value
$14.49B$31.48B
Dividend Yield
—0.4%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Halozyme Therapeutics Inc. Common Stock

Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.

Read more on HALO →

About Interactive Brokers Group Inc. Class A Common Stock

Interactive Brokers operates an electronic brokerage platform for trading stocks, options, futures, currencies, and other assets. It also provides clearing and custody services.

Read more on IBKR →